Cargando…
Development of the Crohn's disease digestive damage score, the Lémann score
Crohn's disease (CD) is a chronic progressive destructive disease. Currently available instruments measure disease activity at a specific point in time. An instrument to measure cumulative structural damage to the bowel, which may predict long-term disability, is needed. The aim of this article...
Autores principales: | Pariente, Benjamin, Cosnes, Jacques, Danese, Silvio, Sandborn, William J, Lewin, Maïté, Fletcher, Joel G, Chowers, Yehuda, D'Haens, Geert, Feagan, Brian G, Hibi, Toshifumi, Hommes, Daniel W, Irvine, E Jan, Kamm, Michael A, Loftus, Edward V, Louis, Edouard, Michetti, Pierre, Munkholm, Pia, Oresland, Tom, Panés, Julian, Peyrin-Biroulet, Laurent, Reinisch, Walter, Sands, Bruce E, Schoelmerich, Juergen, Schreiber, Stefan, Tilg, Herbert, Travis, Simon, van Assche, Gert, Vecchi, Maurizio, Mary, Jean-Yves, Colombel, Jean-Frédéric, Lémann, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116198/ https://www.ncbi.nlm.nih.gov/pubmed/21560202 http://dx.doi.org/10.1002/ibd.21506 |
Ejemplares similares
-
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials
por: Cutsem, E Van, et al.
Publicado: (2004) -
Impact of screening for breast cancer in high-risk women on health-related quality of life
por: Rijnsburger, A J, et al.
Publicado: (2004) -
Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease
por: Halawani, Hajar, et al.
Publicado: (2020) -
“I can’t tell whether it’s my hand”: a pilot study of the neurophenomenology of body representation during the rubber hand illusion in trauma-related disorders
por: Rabellino, Daniela, et al.
Publicado: (2016) -
A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY
por: Panaccione, R, et al.
Publicado: (2022)